Kamby C - Search Results

1

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.

Svane IM, Pedersen AE, Johansen JS, Johnsen HE, Nielsen D, Kamby C, Ottesen S, Balslev E, Gaarsdal E, Nikolajsen K, Claesson MH. Svane IM, et al. Among authors: kamby c. Cancer Immunol Immunother. 2007 Sep;56(9):1485-99. doi: 10.1007/s00262-007-0293-4. Epub 2007 Feb 7. Cancer Immunol Immunother. 2007. PMID: 17285289 Free PMC article. Clinical Trial.

2

Prognostic indicators of metastatic bone disease in human breast cancer.

Kamby C, Rasmussen BB, Kristensen B. Kamby C, et al. Cancer. 1991 Nov 1;68(9):2045-50. doi: 10.1002/1097-0142(19911101)68:9<2045::aid-cncr2820680933>3.0.co;2-e. Cancer. 1991. PMID: 1913553

3

Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer.

Johansen JS, Cintin C, Jørgensen M, Kamby C, Price PA. Johansen JS, et al. Among authors: kamby c. Eur J Cancer. 1995;31A(9):1437-42. doi: 10.1016/0959-8049(95)00196-p. Eur J Cancer. 1995. PMID: 7577068

4

[Follow-up after surgery for breast cancer].

Soot ML, Nielsen DL, Kamby C. Soot ML, et al. Among authors: kamby c. Ugeskr Laeger. 2002 May 27;164(22):2918-22. Ugeskr Laeger. 2002. PMID: 12082822 Review. Danish.

5

Impact of high-dose chemotherapy on antigen-specific T cell immunity in breast cancer patients. Application of new flow cytometric method.

Svane IM, Nikolajsen K, Hansen SW, Kamby C, Nielsen DL, Johnsen HE. Svane IM, et al. Among authors: kamby c. Bone Marrow Transplant. 2002 Apr;29(8):659-66. doi: 10.1038/sj.bmt.1703521. Bone Marrow Transplant. 2002. PMID: 12180110

6

[Radiotherapy of primary breast cancer. An analysis of a systematic Cochrane review].

Nielsen DL, Kamby C. Nielsen DL, et al. Among authors: kamby c. Ugeskr Laeger. 2003 Jan 13;165(3):219-21. Ugeskr Laeger. 2003. PMID: 12555702 Danish. No abstract available.

7

Acute and late toxicity following adjuvant high-dose chemotherapy for high-risk primary operable breast cancer--a quality assessment study.

Svane IM, Homburg KM, Kamby C, Nielsen DL, Roer O, Sliffsgaard D, Johnsen HE, Hansen SW. Svane IM, et al. Among authors: kamby c. Acta Oncol. 2002;41(7-8):675-83. Acta Oncol. 2002. PMID: 14651213

8

Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study.

Svane IM, Pedersen AE, Johnsen HE, Nielsen D, Kamby C, Gaarsdal E, Nikolajsen K, Buus S, Claesson MH. Svane IM, et al. Among authors: kamby c. Cancer Immunol Immunother. 2004 Jul;53(7):633-41. doi: 10.1007/s00262-003-0493-5. Epub 2004 Feb 25. Cancer Immunol Immunother. 2004. PMID: 14985857 Free PMC article. Clinical Trial.

9

[Taxanes in metastatic breast cancer. An analysis of a systematic Cochrane review].

Nielsen DL, Kamby C. Nielsen DL, et al. Among authors: kamby c. Ugeskr Laeger. 2006 Sep 11;168(37):3117-20. Ugeskr Laeger. 2006. PMID: 16999914 Review. Danish. No abstract available.

10

Ejlertsen B, Mouridsen HT, Jensen MB, Bengtsson NO, Bergh J, Cold S, Edlund P, Ewertz M, de Graaf PW, Kamby C, Nielsen DL. Ejlertsen B, et al. Among authors: kamby c. J Clin Oncol. 2006 Nov 1;24(31):4956-62. doi: 10.1200/JCO.2005.05.1235. J Clin Oncol. 2006. PMID: 17075113 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page